Adient stock price target raised to $22 from $20 at CFRA on improved outlook

Published 07/08/2025, 14:20
Adient stock price target raised to $22 from $20 at CFRA on improved outlook

Investing.com - CFRA has raised its price target on Adient (NYSE:ADNT) to $22.00 from $20.00 while maintaining a Hold rating on the automotive seating supplier. Currently trading at $22.88, InvestingPro analysis suggests the stock is undervalued, with 6 analysts recently revising their earnings estimates upward.

The research firm increased its adjusted earnings per share estimates for the company to $1.95 from $1.85 for fiscal year 2025 and to $2.20 from $2.00 for fiscal year 2026, following Adient’s slight earnings miss but higher guidance for FY25.

CFRA’s new price target is based on a fiscal year 2026 price-to-earnings ratio of 10.0x, which represents a discount to Adient’s historical multiples that the firm considers justified.

The research firm acknowledged that Adient’s management has successfully implemented strategic initiatives including asset sales, debt refinancing, and tariff impact mitigation, noting that shares have more than doubled from their early April lows.

CFRA expressed concern that Adient’s seating products face greater exposure to competition and global production rates compared to suppliers in higher-growth segments like autonomous driving software or electrification, with 60% of the company’s FY24 net sales coming from plants located outside the United States.

In other recent news, UBS has adjusted its price target for Adient to $26.00, up from the previous target of $25.00. The investment bank continues to hold a Neutral rating on the company. This adjustment comes as UBS acknowledges Adient’s ongoing solid business performance. Additionally, UBS highlighted that Adient is likely to benefit from the trend of manufacturing reshoring to the United States. These developments reflect the investment bank’s assessment of the company’s current market position. Investors might find this information useful when considering Adient’s potential for future growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.